When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Brucellosis

Last reviewed: 9 Dec 2025
Last updated: 21 Oct 2025

Summary

Definition

History and exam

Key diagnostic factors

  • history of contact with infected person
  • fever or chills
  • constitutional symptoms
  • arthralgia
  • joint swelling and tenderness
  • hepatomegaly and/or splenomegaly
Full details

Other diagnostic factors

  • nausea, vomiting, abdominal pain, constipation, diarrhea
  • pallor
  • lymphadenopathy
  • dry cough
  • chest signs
  • testicular pain
  • neck stiffness
  • cranial nerve palsy or focal central nervous system deficit
  • dullness to percussion, decreased air entry, crepitations
  • red eye
  • skin rashes
Full details

Risk factors

  • ingestion of contaminated foods
  • exposure to infected animal products
  • inhalation of infected aerosols
  • conjunctival contact with infected material
  • occupation with potential for exposure to Brucella species
  • travel to an endemic area
  • cuts or abrasions in skin
  • sexual contact with infected individual
  • newborn or infant of infected mother
  • recipient of blood products or of organ or tissue transplant
Full details

Diagnostic tests

1st tests to order

  • blood culture
  • serologic tests
  • cerebrospinal fluid (CSF) analysis
  • cerebrospinal fluid (CSF) culture
  • synovial fluid analysis
  • synovial fluid culture
  • CBC
  • liver function tests
  • serum electrolytes
Full details

Tests to consider

  • bone marrow culture
  • tissue biopsy
  • plain film x-rays of affected joints
  • chest x-ray
  • bone scan
  • CT or MRI scan of spine
  • CT or MRI scan of head
Full details

Emerging tests

  • polymerase chain reaction for detection and diagnosis of Brucella species
  • matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry

Treatment algorithm

ACUTE

uncomplicated disease

complicated disease

Contributors

Authors

Nicholas J. Beeching, MA, BM BCh, FRCP, FRACP, FFTM RCPS (Glasg), FESCMID, DCH, DTM&H

Consultant and Emeritus Professor of Tropical and Infectious Diseases

Royal Liverpool University Hospital

Liverpool School of Tropical Medicine

Liverpool

UK

Declarações

NJB is partially supported by the National Institute of Health Research Health Protection Unit in Emerging and Zoonotic Infections at the University of Liverpool and the UK Health Security Agency. Views expressed in this topic are those of the contributor and do not necessarily represent the official position of the National Health Service, the National Institute for Health Research, the Department of Health, or the UK Health Security Agency. NJB is an author of references cited in this topic.

Alessandro Gerada, MD, MRCP, FRCPath

Consultant in Clinical Microbiology

Liverpool Clinical Laboratories

Royal Liverpool University Hospital

Liverpool

UK

Declarações

AG is an author of several references cited in this topic.

Sherine Thomas, MBChB, MRCP, DTMH

Consultant in Infectious Diseases

Whipps Cross Hospital

London

UK

Declarações

ST declares that she has no competing interests.

Revisores

Mical Paul, MD

Infectious Diseases Consultant

Unit of Infectious Diseases

Rabin Medical Center

Beilinson Hospital

Petah-Tikva

Israel

Declarações

MP declares that she has no competing interests.

Edward J. Young, MD

Professor of Medicine

Section of Infectious Diseases

Department of Medicine

Baylor College of Medicine

Houston

TX

Declarações

EJY declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Centers for Disease Control and Prevention. Brucellosis reference guide: exposures, testing and prevention. Feb 2017 [internet publication].Texto completo

World Health Organization. Brucellosis in humans and animals. 2006 [internet publication].Texto completo

Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, et al. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007179.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal